Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Hemodynamic Instability Rules Based Advisor: The Impact to Care With a New Predictive Indicator (HIRBA 2.0)

NCT02185521 is registered in ClinicalTrials.gov with Philips Healthcare as lead sponsor.

NCT NCT02185521
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02185521 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Hemodynamic Instability Rules Based Advisor: The Impact to Care With a New Predictive Indicator (HIRBA 2.0)
Lead sponsor
Philips Healthcare
Phase
Not applicable
Overall status
Terminated
Start date
March 1, 2016
Completion date
November 18, 2016
Enrollment
127 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

hemodynamic instability, shock